Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 15, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-24
DOI
10.3389/fnins.2021.785276
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer’s disease
- (2021) Stefania Forner et al. Scientific Data
- Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study
- (2020) Frank de Wolf et al. BRAIN
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain
- (2020) Joshua D. Crapser et al. EBioMedicine
- Large-scale discovery of mouse transgenic integration sites reveals frequent structural variation and insertional mutagenesis
- (2019) Leslie O. Goodwin et al. GENOME RESEARCH
- Dissociable cognitive impairments in two strains of transgenic Alzheimer’s disease mice revealed by a battery of object-based tests
- (2019) Samantha D. Creighton et al. Scientific Reports
- Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's disease
- (2019) Désirée H. Veening-Griffioen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The neuropathological diagnosis of Alzheimer’s disease
- (2019) Michael A. DeTure et al. Molecular Neurodegeneration
- Facing the complexity of Alzheimer's disease
- (2019) Patrick Dallemagne et al. Future Medicinal Chemistry
- Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer’s Disease
- (2018) Jun-Ting Yang et al. Neuroscience Bulletin
- Temporal and regional progression of Alzheimer’s disease-like pathology in 3xTg-AD mice
- (2018) Ramona Belfiore et al. AGING CELL
- Alzheimer’s disease: experimental models and reality
- (2016) Eleanor Drummond et al. ACTA NEUROPATHOLOGICA
- Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer’s disease
- (2015) Milene Vandal et al. FASEB JOURNAL
- Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level
- (2015) Katherine R Sadleir et al. Molecular Neurodegeneration
- Simplification of the modified Gallyas method
- (2014) Nobuo Kuninaka et al. NEUROPATHOLOGY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Sex-Dependent Alterations in Social Behaviour and Cortical Synaptic Activity Coincide at Different Ages in a Model of Alzheimer’s Disease
- (2012) Cyril Bories et al. PLoS One
- ST101 induces a novel 17kDa APP cleavage that precludes Aβ generation in vivo
- (2011) Kim N. Green et al. ANNALS OF NEUROLOGY
- Sex differences in β-amyloid accumulation in 3xTg-AD mice: Role of neonatal sex steroid hormone exposure
- (2010) Jenna C. Carroll et al. BRAIN RESEARCH
- Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice
- (2010) Sylvia E. Perez et al. NEUROBIOLOGY OF DISEASE
- Selective Estrogen Receptor Modulators Differentially Regulate Alzheimer-Like Changes in Female 3xTg-AD Mice
- (2008) Jenna C. Carroll et al. ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started